RxDoctor Payments Data

Charles Chiu

Infectious Disease · San Francisco, CANPI 1598797268

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,105 of the $13,449 with a category attached, or 75.1%. Reporting peaked in 2020 at $8,110 and has fallen 99.3% since, to $54 in 2024. Among infectious disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,449in general payments, 2019–2025

Across 20 payments — averaging $672.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cepheid$8K
  • Abbott$5K
$962,500in research payments, 2019–2025

Across 3 payments — averaging $320,833 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$963K

What the payments were for

  • Consulting fees$10,10575%
  • Travel & lodging$3,12023%
  • Food & beverage$2242%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cepheid3$7,980
Abbott17$5,469

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,449 in reported general payments places this provider in the 90th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California

Other infectious disease in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →